Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: a rapid review and meta‐analysis
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID‐19: A systematic review and meta‐analysis
This study aimed to compare the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) with
molnupiravir in the treatment of coronavirus disease 2019 (COVID‐19). To end this …
molnupiravir in the treatment of coronavirus disease 2019 (COVID‐19). To end this …
Nirmatrelvir–ritonavir compared with other antiviral drugs for the treatment of COVID‐19 patients: A systematic review and meta‐analysis
F Tian, Z Chen, Q Feng - Journal of Medical Virology, 2023 - Wiley Online Library
At present, there are some differences in the research results of nirmatrelvir–ritonavir
compared with other antiviral drugs for the treatment of COVID‐19 patients. We aimed to …
compared with other antiviral drugs for the treatment of COVID‐19 patients. We aimed to …
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
H Tian, C Yang, T Song, K Zhou, L Wen… - Reviews in Medical …, 2023 - Wiley Online Library
Our study is aimed to access the efficacy and safety outcomes for coronavirus disease 2019
(COVID‐19) patients treated with Paxlovid. According to inclusion and exclusion criteria …
(COVID‐19) patients treated with Paxlovid. According to inclusion and exclusion criteria …
Nirmatrelvir–ritonavir for the treatment of COVID‐19 patients: A systematic review and meta‐analysis.
The landscape of development of treatment modalities and preventive measures for COVID-
19 has progressed expeditiously since the beginning of the pandemic. We included all the …
19 has progressed expeditiously since the beginning of the pandemic. We included all the …
[HTML][HTML] Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
Despite the need for novel, effective therapeutics for the COVID-19 pandemic, no curative
regimen is yet available, therefore patients are forced to rely on supportive and nonspecific …
regimen is yet available, therefore patients are forced to rely on supportive and nonspecific …
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19
S Reis, MI Metzendorf, R Kuehn… - Cochrane Database …, 2023 - cochranelibrary.com
Background Oral nirmatrelvir/ritonavir (Paxlovid) aims to avoid severe COVID‐19 in
asymptomatic people or those with mild symptoms, thereby decreasing hospitalization and …
asymptomatic people or those with mild symptoms, thereby decreasing hospitalization and …
[HTML][HTML] Lopinavir/ritonavir for COVID-19: a living systematic review
Objective Provide a timely, rigorous, and continuously updated summary of the evidence on
the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods We …
the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods We …
Efficacy and safety of lopinavir/ritonavir for treatment of COVID-19: a systematic review and meta-analysis
S Alhumaid, A Al Mutair, Z Al Alawi, N Alhmeed… - Tropical medicine and …, 2020 - mdpi.com
(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV)
antiviral combination that has been considered for the treatment of COVID-19 disease.(Aim) …
antiviral combination that has been considered for the treatment of COVID-19 disease.(Aim) …
[HTML][HTML] Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
TK Patel, PB Patel, M Barvaliya, MK Saurabh… - Journal of Infection and …, 2021 - Elsevier
Background Lopinavir-ritonavir is a repurposed drug for coronavirus disease-2019 (COVID-
19). In this study, a pooled effect of lopinavir-ritonavir on mortality, virological cure …
19). In this study, a pooled effect of lopinavir-ritonavir on mortality, virological cure …
相关搜索
- efficacy and safety covid 19
- meta analysis covid 19
- efficacy and safety meta analysis
- nirmatrelvir ritonavir covid 19
- nirmatrelvir ritonavir meta analysis
- efficacy and safety lopinavir ritonavir
- nirmatrelvir ritonavir safety of paxlovid
- lopinavir ritonavir covid 19
- efficacy and safety nirmatrelvir ritonavir
- safety of paxlovid covid 19
- safety of paxlovid meta analysis
- meta analysis ritonavir for the treatment
- ritonavir therapy covid 19
- meta analysis lopinavir ritonavir